Literature DB >> 23402680

Physical therapy program for cervical dystonia: a study of 20 cases.

Mariana Araujo Ribeiro Queiroz1, Hsin Fen Chien, Flávio Augusto Sekeff-Sallem, Egberto Reis Barbosa.   

Abstract

Botulinum toxin (BTX) is the best therapeutic option inpatients with cervical dystonia (CD), but physical therapy (PT) can be added to the treatment to achieve better results. Forty of our 70 patients with CD were en-rolled in a controlled open study. Subjects were divided into two groups: G1 (intervention group comprising patients receiving BTX and PT) and G2 (control group comprising patients receiving BTX only). Both groups were assessed using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) and the 36-Item Short-Form Health Survey (SF-36). On the TWSTRS, significant improvements in disease severity were seen in G1 and G2 but significant improvements on the pain and disability subscales were seen only in G1 patients.There was a significant difference only on the pain sub-scale between G2 and G1 following treatment. An analysis of the physical aspects of SF-36 showed significant improvement in G1 on three subscales. An intergroup difference was also seen on two subscales.Regarding emotional aspects, G1 showed a significant improvement on three subscales. A significant difference on two subscales was also seen between G2 and G1 following treatment. BTX plus PT treatment achieved symptom relief in patients with CD and improved their quality of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23402680      PMCID: PMC3812762     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  23 in total

1.  Impact of cervical dystonia on quality of life.

Authors:  Laura Camfield; Yoav Ben-Shlomo; Thomas T Warner
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

Review 2.  Rehabilitation of movement disorders.

Authors:  Ross A Bogey; Elie P Elovic; Phillip R Bryant; Carolyn C Geis; Alex Moroz; Bryan J O'Neill
Journal:  Arch Phys Med Rehabil       Date:  2004-03       Impact factor: 3.966

3.  Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital.

Authors:  Mariana Ribeiro Queiroz; Hsin Fen Chien; Egberto Reis Barbosa
Journal:  Arq Neuropsiquiatr       Date:  2011-12       Impact factor: 1.420

4.  Effect of prolonged neck muscle vibration on lateral head tilt in severe spasmodic torticollis.

Authors:  H O Karnath; J Konczak; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

5.  Effect of dystonia and botulinum toxin treatment on health-related quality of life.

Authors:  C M Gudex; M R Hawthorne; A G Butler; P Duffey
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

6.  The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.

Authors:  J Müller; G Kemmler; J Wissel; A Schneider; B Voller; J Grossmann; J Diez; N Homann; G K Wenning; P Schnider; W Poewe
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

7.  Muscle relaxation is impaired in dystonia: a reaction time study.

Authors:  Alessandro Buccolieri; Laura Avanzino; Lucio Marinelli; Carlo Trompetto; Roberta Marchese; Giovanni Abbruzzese
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

8.  Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.

Authors:  J Jankovic; K S Schwartz
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  The effect of two different rehabilitation treatments in cervical dystonia: preliminary results in four patients.

Authors:  Nicola Smania; Elisabetta Corato; Michele Tinazzi; Barbara Montagnana; Antonio Fiaschi; Salvatore M Aglioti
Journal:  Funct Neurol       Date:  2003 Oct-Dec

10.  Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.

Authors:  Arja Häkkinen; Jari Ylinen; Mira Rinta-Keturi; Ulla Talvitie; Hannu Kautiainen; Aimo Rissanen
Journal:  Arch Phys Med Rehabil       Date:  2004-10       Impact factor: 3.966

View more
  13 in total

Review 1.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

Review 3.  Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Authors:  Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen
Journal:  Front Neurol       Date:  2017-02-24       Impact factor: 4.003

4.  Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck Cancer.

Authors:  Talya Salz; Rebecca B Schnall; Mary S McCabe; Kevin C Oeffinger; Stacie Corcoran; Andrew J Vickers; Andrew L Salner; Ellen Dornelas; Nirupa J Raghunathan; Elizabeth Fortier; Janet McKiernan; David J Finitsis; Susan Chimonas; Shrujal Baxi
Journal:  JCO Clin Cancer Inform       Date:  2018-12

5.  Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.

Authors:  Marcello Romano; Sergio Bagnato; Maria Concetta Altavista; Laura Avanzino; Daniele Belvisi; Matteo Bologna; Francesco Bono; Miryam Carecchio; Anna Castagna; Roberto Ceravolo; Antonella Conte; Giuseppe Cosentino; Roberto Eleopra; Tommaso Ercoli; Marcello Esposito; Giovanni Fabbrini; Gina Ferrazzano; Stefania Lalli; Marcello Maria Mascia; Maurizio Osio; Roberta Pellicciari; Simona Petrucci; Enza Maria Valente; Francesca Valentino; Mario Zappia; Maurizio Zibetti; Paolo Girlanda; Michele Tinazzi; Giovanni Defazio; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2022-10-03       Impact factor: 3.830

Review 6.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

7.  The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors.

Authors:  Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver
Journal:  Contemp Clin Trials       Date:  2021-05-21       Impact factor: 2.261

8.  Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.

Authors:  Joost van den Dool; Bart Visser; J Hans T M Koelman; Raoul H H Engelbert; Marina A J Tijssen
Journal:  BMC Neurol       Date:  2013-07-15       Impact factor: 2.474

Review 9.  Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.

Authors:  Reversa R Mills; Fernando L Pagan
Journal:  Patient Prefer Adherence       Date:  2015-06-02       Impact factor: 2.711

10.  Unmet Needs in the Management of Cervical Dystonia.

Authors:  Maria Fiorella Contarino; Marenka Smit; Joost van den Dool; Jens Volkmann; Marina A J Tijssen
Journal:  Front Neurol       Date:  2016-09-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.